RFA
GTBP icon

Reyes Financial Architecture’s GT Biopharma GTBP Stock Holding History

Reyes Financial Architecture’s Portfolio GTBP Stock Details GTBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$306 Buy
+625
New +$254 ﹤0.01% 313

Other funds holding GTBP

EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
OWA
Opal Wealth Advisors Jericho, New York $463M AUM 20.47% 1-Year Est. Return
SWM
SeaCrest Wealth Management Purchase, New York $903M AUM 47.26% 1-Year Est. Return
AIS
AM Investment Strategies Chattanooga, Tennessee $521M AUM 33.22% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
MFA
Mayflower Financial Advisors Boston, Massachusetts $1.16B AUM 24.36% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
WFA
West Financial Advisors Des Moines, Iowa $659M AUM 17.93% 1-Year Est. Return
TCM
Triumph Capital Management Denver, Colorado $552M AUM 20.75% 1-Year Est. Return

Reyes Financial Architecture's GTBP Position: Q2 2026 in Review

Reyes Financial Architecture opened a new position in GT Biopharma (GTBP) in Q2 2026: 625 shares worth $306. The stake represents ﹤0.01% of the portfolio and ranks #313 among its holdings.

12 funds tracked by Wall St. Rank hold GTBP as of Q2 2026.

  • Reyes Financial Architecture held 625 shares of GT Biopharma worth $306 as of Q2 2026.
  • GT Biopharma was a new Reyes Financial Architecture position in Q2 2026.
  • GT Biopharma made up ﹤0.01% of Reyes Financial Architecture's portfolio in Q2 2026, its #313 holding.
  • 12 funds tracked by Wall St. Rank held GT Biopharma as of Q2 2026.

Based on Reyes Financial Architecture's 13F filing for Q2 2026, filed 17 Jul 2026.